article thumbnail

The Promise and Challenge of Big Data for Pharma

Harvard Business

One of the biggest is how to make the transition from legacy technology and analytical competence to more-powerful and sophisticated analytical tools and analysis methodologies. While these advances are generating great opportunities, they also pose resourcing and capability development challenges. Genentech, which is owned by F.

Data 28
article thumbnail

So Many M&A Deals Fail Because Companies Overlook This Simple Strategy

Harvard Business

The rationale for this approach is highlighted when you compare, for example, the different approaches to M&A employed by a number of legacy pharmaceutical companies and by some relatively newer players in the biotechnology industry.

Company 28